|
Volumn 7, Issue 3, 2001, Pages 203-212
|
Taxane-based chemotherapy for patients with carcinoma of unknown primary site
a a a a a a |
Author keywords
Taxane based chemotherapy for unknown primary carcinoma; Unknown primary carcinoma
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
ETOPOSIDE;
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
AREA UNDER THE CURVE;
ARTHRALGIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CARCINOMA;
CLINICAL TRIAL;
DRUG EFFICACY;
EDEMA;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERSENSITIVITY REACTION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MULTICENTER STUDY;
MYALGIA;
NAUSEA AND VOMITING;
NEUROENDOCRINE TUMOR;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRIDGED COMPOUNDS;
CARBOPLATIN;
CARCINOMA;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS, UNKNOWN PRIMARY;
PACLITAXEL;
SURVIVAL ANALYSIS;
TAXOIDS;
|
EID: 0035715191
PISSN: 15289117
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (55)
|
References (15)
|